S
Suping Guo
Researcher at Sun Yat-sen University
Publications - 7
Citations - 26
Suping Guo is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 3 publications receiving 8 citations.
Papers
More filters
Journal ArticleDOI
Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
TL;DR: A nomogram incorporating hematological biomarkers to predict pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (CRT) in patients with esophageal squamous cell carcinoma (ESCC) was developed and internally validated, showing good predictive performance.
Journal ArticleDOI
Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies.
Sha Zhou,Shiliang Liu,Li Zhang,Suping Guo,Jingxian Shen,Qiaoqiao Li,Hong Yang,Yanfen Feng,Mengzhong Liu,Steven H. Lin,Mian Xi +10 more
TL;DR: Patients with a higher pathologic stage were associated with a significantly higher risk of recurrences and worse survival, and these major findings were successfully reproduced in the Western validation cohort.
Journal ArticleDOI
Modeling the risk of radiation pneumonitis in esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
TL;DR: A nomogram was built with satisfactory prediction ability for the prediction of symptomatic radiation pneumonitis in patients with esophageal squamous cell carcinoma who received definitive concurrent chemoradiotherapy and non-smoking status, 3DCRT, lung V20, and PTV were significantly associated with a higher risk of RP.
Journal ArticleDOI
Multiregional radiomic model for breast cancer diagnosis: value of ultrasound-based peritumoral and parenchymal radiomics
TL;DR: In this article , a multiregional model combining radiomic information of intratumoral, peritumoral, and ipsilateral parenchymal regions yielded better performance than the intra-and intra-abdominant models in distinguishing malignant breast lesions from benign lesions.
Journal ArticleDOI
Efficacy and safety of colistin sulfate in the treatment of infections caused by carbapenem-resistant organisms: a multicenter retrospective cohort study
Danyang Peng,Fan Zhang,Yinyin Chen,Cong-Ying Zhao,Jing-ping Niu,Jianxu Yang,Zhifeng Li,Chao Chen,Shi Qiu,Huifeng Zhang,Bingyu Qin,X. Fang,Suping Guo,Yang Liu,Huanzhang Shao +14 more
TL;DR: In this paper , the authors investigated the rate of clinical improvement and adverse reactions of colistin sulfate in the treatment of severe infections caused by carbapenem-resistant organisms (CRO) in critically ill patients and assessed the factors associated with 28-day all-cause mortality.